In vitro, RDEA119 was found to efficiently inhibit MUC2 transcription in mucin-producing LS174T CRC cells as well as in PMP tumor explants by reducing ERK1/2 phosphorylation [84]. This evidence concerns the gene MUC5AC and colorectal carcinoma.